MDA-MB-231 is a highly invasive triple-negative breast cancer (TNBC) cell line, i.e., the cells are negative for hormone receptors (estrogen and progesterone) and HER2 making it more difficult to target them with therapies [26]. Here, ERBB2 is linked to triple-negative breast carcinoma.